RANTES expression and contribution to monocyte chemotaxis in arthritis

Clinical Immunology and Immunopathology

Volumn 89, Issue 1, 1998, Pages 44-53

  Volin, Michael V ^a   Shah, Manisha R ^a   Tokuhira, Michihide ^a   Haines III, G Kenneth ^a   Woods, James M ^a   Koch, Alisa E ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Department of Rheumatology   (United States)

Author keywords

Chemokine; Chemotaxis; Rheumatoid arthritis

Indexed keywords

CD45 ANTIGEN; CHEMOATTRACTANT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MAJOR CLINICAL STUDY; MEMORY CELL; MONOCYTE; MONONUCLEAR CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0032189968     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4590     Document Type: Article

References (46)

1. Harris E. D. Jr. Rheumatoid arthritis: Pathophysiology and implications for therapy. N. Engl. J. Med. 332:1990;1277-1289.
2. Rathanaswami P., Hachicha M., Sadick M., Schall R. J., McColl S. R. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. J. Biol. Chem. 268:1993;5834-5839.
3. Robinson E., Keystone E. C., Schall T. J., Gillett N., Fish E. N. Chemokine expression in rheumatoid arthritis (RA): Evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells. Clin. Exp. Immunol. 101:1995;398-407.
4. Jordan N. J., Watson M. L., Westwick J. The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells. Biochem. J. 311:1995;89-95.
5. Koch A. E., Kunkel S. L., Harlow L. A., Johnson B., Evanoff H. L., Haines G. K., Burdick M. D., Pope R. M., Strieter R. M. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90:1992;772-779.
6. Kasama T., Strieter R. M., Lukacs N. W., Lincoln P. M., Burdick M. D., Kunkel S. L. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95:1995;2868-2876.
7. Hogan M., Sherry B., Ritchlin C., Fabre M., Winchester R., Cerami A., Bucala R. Differential expression of the small inducible cytokines GRO alpha and GRO beta by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine. 6:1994;61-69.
8. Uemori E. N., Amento E. P., Bauer E. A., Horuk R. Melanoma growth-stimulatory activity/GRO decreases collagen expression by human fibroblasts: Regulation by C-X-C but not C-C cytokines. J. Biol. Chem. 268:1993;1338-1342.
9. Beaulieu A. D., McColl S. R. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonist, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum. 37:1994;855-859.
10. Koch A. E., Kunkel S. L., Harlow L. A., Mazarakis D. D., Haines G. K., Burdick M. D., Pope R. M., Strieter R. M. Macrophage inflammatory protein-1 alpha: A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J. Clin. Invest. 93:1994;921-928.
11. Seitz M., Loetscher P., Dewald B., Towbin H., Ceska M., Baggiolini M. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostoglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-gamma and IL-4. J. Immunol. 152:1994;2060-2065.
12. Koch A. E., Kunkel S. L., Shah M. R., Fu R., Mazarakis D. D., Haines G. K., Burdick M. D., Pope R. M., Strieter R. M. Macrophage inflammatory protein-1 beta: A C-C chemokine in osteoarthritis. Clin. Immunol. Immunopathol. 77:1995;307-314.
13. Wang J. H., Devalia J. L., Xia C., Sapsford R. J., Davies R. J. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am. J. Respir. Cell Mol. Biol. 14:1996;27-35.
14. Devergne O., Margaing-Koka A., Schall T. J., Leger-Ravet M. B., Sadick M., Peuchmaur M., Crevon M. C., Kim K. J. Production of RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J. Exp. Med. 179:1994;1689-1694.
15. Marfaing-Koka A., Devergne O., Gorgone G., Portier A., Schall T. J., Galanaud P., Emilie D. Regulation of the production of the RANTES chemokine by endothelial cells: Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J. Immunol. 154:1995;1870-1878.
16. Schall T. J., Bacon K., Toy K. J., Goeddel D. V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature. 347:1990;669-671.
17. Rot A., Krieger M., Brunner T., Bischoff S. C., Schall T. J., Dahinden C. A. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1992;1489-1495.
18. von Luettichau I., Nelson P. J., Pattison J. M., van de Rijn M., Huie P., Warnke R., Wiedermann C. J., Stahl R. A., Sibley R. K., Krensky A. M. RANTES chemokine expression in diseased and normal human tissues. Cytokine. 8:1996;89-98.
19. Hosaka S., Akahoshi T., Wada C., Kondo H. Expression of the chemokine superfamily in rheumatoid arthritis. Clin. Exp. Immunol. 97:1994;451-457.
20. Arnett F. C., Edworth S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S., Medsger T. A. J., Mitchell D. M., Neustadt D. H., Pinals R. S., Schaller J. G., Sharp J. T., Wilder R. L., Hunder G. G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:1988;315-324.
21. Altman R., Asch E., Bloch D., Bole G., Borenstein D., Brandt K., Christy W., Cooke T. D., Greenwald R., Hochberg M., Howell D., Kaplan D., Koopman W., Longley S., Mankin H., McShane D. J., Medsger T. J., Meenan R., Mikkelsen W., Moskowitz R., Murphy W., Rothschild B., Segal M., Sokoloff L., Wolfe F. Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee. Arthritis Rheum. 29:1986;1039-1049.
22. Koch A. E., Haines G. K., Rizzo R. J., Radosevich J. A., Pope R. M., Robinson P. G., Pearce W. Human abdominal aortic aneurysms: immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol. 137:1990;1199-1213.
23. Koch A. E., Radosevich J. A., Robinson P. G., Pope R. M. Distribution of CD45RA+ and CD45RO+ T lymphocyte subsets in rheumatoid arthritis synovial tissue. J. Clin. Immunol. 10:1990;192-199.
24. Koch A. E., Burrows J. C., Marder R. M., Domer P. H., Leibovich S. J. Reactivity of human tissues with monoclonal antibodies to myeloid activation and differentiation antigens. Pathobiology. 58:1990;241-248.
25. Koch A. E., Polverini P. J., Leibovich S. J. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 29:1986;471-479.
26. Koch A. E., Polverini P. J., Leibovich S. J. Functional heterogeneity of human rheumatoid synovial tissue macrophages. J. Rheumatol. 15:1988;1058-1063.
27. Koch A. E., Kunkel S. L., Burrows J. C., Evanoff H. L., Haines G. K., Pope R. M., Strieter R. M. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J. Immunol. 147:1991;2187-2195.
28. Koch A. E., Kunkel S. L., Shah M. R., Hosaka S., Halloran M. M., Haines G. K., Burdick M. D., Pope R. M., Strieter R. M. Growth-related gene product alpha: A chemotactic cytokine for neutrophils in rheumatoid arthritis. J. Immunol. 155:1995;3660-3666.
29. Pope R. M., Landay A., Modlin R. L., Lessard J., Koch A. E. τ/δ T cell receptor positive T cells in the inflammatory joint: lack of association with response to soluble antigens. Cell Immunol. 137:1991;127-138.
30. Koch A. E., Kunkel S. L., Harlow L. A., Mazarakis D. D., Haines G. K., Burdick M. D., Pope R. M., Walz A., Strieter R. M. Epithelial neutrophil activating peptide-78: A novel chemotactic cytokine for neutrophils in arthritis. J. Clin. Invest. 94:1994;1012-1018.
31. Schall T. J., Jongstra J., Dyer B. J., Jorgensen J., Clayberger C., Davis M. M., Krensky A. M. A human T cell-specific molecule is a member of a new gene family. J. Immunol. 141:1988;1018-1025.
32. Jordan N. J., Watson M. L., Yoshimura T., Westwick J. Differential effects of protein kinase C inhibitors on chemokine production in human synovial fibroblasts. Br. J. Pharmacol. 117:1996;1245-1253.
33. Brennan F. M., Zachariae C. O., Chantry D., Larsen C. G., Turner M., Maini R. N., Matsushima K., Feldmann M. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur. J. Immunol. 20:1990;2141-2144.
34. Smolen J. S., Tohidast-Akrad M., Gal A., Kunaver M., Eberl G., Zenz P., Falus A., Steiner G. The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand. J. Rheumatol. 25:1996;1-4.
35. Ezawa K., Yamamura M., Matsui H., Ota Z., Makino H. Comparative analysis of CD45RA- and CD45RO-positive CD4+T cells in peripheral blood, synovial fluid, and synovial tissue in patients with rheumatoid arthritis and osteoarthritis. Acta Med. Okayama. 51:1997;25-31.
36. Hopkins S. J., Meager A. cytokines in synovial fluid, II. The presence of tumour necrosis factor and interferon. Clin. Exp. Immunol. 73:1988;88-92.
37. Di Giovine F. S., Nuki G., Duff G. W. Tumour necrosis factor in synovial exudates. Ann. Rheum. Dis. 47:1988;768-772.
38. Schlaak J. F., Pfers I., Meyer Zum Buschenfelde K. H., Marker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheumatol. 14:1996;155-162.
39. Westacott C. I., Whicher J. T., Barnes I. C., Thompson D., Swan A. J., Dieppe P. A. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann. Rheum. Dis. 49:1990;676-681.
40. Swaak A. J., van Rooyen A., Nieuwenhuis E., Aarden L. A. Interleukin-6 (IL-6) in synovial fluid and serum of patients with rheumatic diseases. Scand. J. Rheumatol. 17:1988;469-474.
41. Brandt K. D., Mankin H. J. Pathogenesis of osteoarthritis. Textbook in Rheumatology. 1993;Saunders, Philadelphia. p. 1417-1431.
42. MacNaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 265:1990;17238-17245.
43. Dayer J. M., Beutler B., Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:1985;2163-2168.
44. 2. J. Clin. Invest. 77:1986;645-648.
45. Brennan F. M., Zachariae C. O. C., Chantry D., Larsen C. G., Turner M., Maini R. N., Matsushima K., Feldmann M. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur. J. Immunol. 20:1990;2141-2144.
46. Remick D. G., DeForge L. E., Sullivan J. F., Showell H. J. Profile of cytokines in synovial fluid specimens from patients with arthritis. Immunol. Invest. 21:1992;321-327.